Abstract
A new .beta.-cyclodextrin (CD) bonded silica has been designed for direct injection analysis of drug enantiomers in serum for liquid chromatography. The new .beta.-CD bonded silica is synthesized by three steps: introduction of a 3-glycidoxypropyl phase, introduction of a .beta.-CD carbamate-bonded phase, and hydrolysis of the oxirane ring to a diol phase. Although the recovery of serum proteins from only a .beta.-CD bonded silica (having no diol phase) was poor, they were completely recovered from a mixed functional silica having .beta.-CD and diol phases. Direct injection analysis of drug enantiomers in serum can be attained with the mixed functional silica support over the eluent pH range of 3-7. The recovery of racemic drugs from serum was almost 100%.

This publication has 0 references indexed in Scilit: